Matthew Ros, former EVP, Chief Strategy & Business Officer of Epizyme, joins Fore as Chief Executive Officer and Director of the Board Fore…

Acquisition includes wholly owned subsidiary businesses BioKey BV and BioClue BV. Platform is based on a proprietary biological discovery…

Highly Accomplished Thought Leader with Proven Track Record of Immunotherapy Drug Development Ankyra Therapeutics, a company developing cancer…

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics as prescription medical treatments, announced the formation of a Scientific…

Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research to help people live longer,…

-Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics as prescription medical treatments, announced updates from multiple early…

tNova platform leverages the world's most dense and precise microarray to discover and develop transformative therapeutics Series A Financing led by…

KetamineOne Capital Limited, an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital…

- Top-tier investors Khosla Ventures and Future Ventures led the financing round - Founding team includes the world’s leading cancer researchers and…

On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration (FDA) to…